Document Detail

Novel Approaches to the Treatment of Obesity and Type 2 Diabetes Mellitus: Bioactive Leptin-Related Synthetic Peptide Analogs.
MedLine Citation:
PMID:  21913885     Owner:  NLM     Status:  Publisher    
Leptin, the protein product of the ob gene, is primarily an adipocyte-secreted hormone, whose functional significance is rapidly expanding. Although early research efforts were focused on defining leptin's role in reversing obesity in rodents, there is now substantial evidence indicating that its influence extends to a number of hypothalamic-pituitary- endocrine axes, including adrenal, gonadal, growth hormone, pancreatic islets, and thyroid. The pleiotropic nature of leptin has been confirmed by demonstration of a role for leptin in hematopoiesis, angiogenesis, immune function, osteogenesis, reproduction, and wound healing. Unfortunately, the results of the majority of clinical trials with recombinant human leptin indicated that its effectiveness in restoring energy balance and correcting obesity-related endocrinopathies in genetically obese rodent models extended only to the management of those rare forms of human obesity caused by mutation in the ob gene. Failure of leptin in the clinic, and withdrawal of fenfluramine, phentermine, and sibutrimine from clinical use in the United States, have stimulated new approaches in the development of anti-obesity and anti-diabetes pharmacophores. These efforts are focused on utilizing leptin-related synthetic peptides as leptin receptor antagonists or leptin-related synthetic peptide analogs or mimetics. This review summarizes patents on leptin-related peptide analogs, antagonists and mimetics.
Patricia Grasso
Related Documents :
15583005 - Tandemly duplicated acyl carrier proteins, which increase polyketide antibiotic product...
14602605 - Modification of the monomer composition of polyhydroxyalkanoate synthesized in saccharo...
17900615 - Crystal structure of human pus10, a novel pseudouridine synthase.
12788765 - A c35 carotenoid biosynthetic pathway.
8622685 - The regulatory domain of human heat shock factor 1 is sufficient to sense heat stress.
15894545 - Reconstruction of the conserved beta-bulge in mammalian defensins using d-amino acids.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-9
Journal Detail:
Title:  Recent patents on endocrine, metabolic & immune drug discovery     Volume:  -     ISSN:  1872-2148     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-9-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101299743     Medline TA:  Recent Pat Endocr Metab Immune Drug Discov     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Medicine, Division of Endocrinology and Metabolism Albany Medical College, MC 141, Albany, NY 12208, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Current and Future Development of Estrogen Receptor Ligands: Applications in Estrogen-Related Cancer...
Next Document:  Immunomodulatory properties of thalidomide analogs: pomalidomide and lenalidomide, experimental and ...